• SENSEX 82,570.91
    317.45 (+0.39%)
  • BANKNIFTY 57,006.65
    241.30 (+0.43%)
  • Ola Electric
    43.66 39.58(%)
  • HDFC Bank
    2,003.00 2,027.40(%)
  • Waaree Renewab.
    1,166.00 2,074.95(%)
  • ICICI Bank
    1,433.80 1,471.10(%)
  • Infosys
    1,603.80 2,006.80(%)
  • Neuland Labs.
    15,499.00 18,089.55(%)
  • Reliance Industr
    1,496.05 1,605.73(%)
  • JP Power Ven.
    24.50 12.35(%)
  • Swan Energy
    514.00 809.70(%)
  • Indian Hotels Co
    747.05 894.15(%)
  • TCS
    3,259.80 4,585.90(%)
  • Suzlon Energy
    67.39 86.04(%)
  • Tega Inds.
    1,860.00 2,327.45(%)
  • Godfrey Phillips
    9,824.00 9,824.00(%)
  • Rallis India
    347.05 196.00(%)
  • Tejas Networks
    629.65 629.65(%)
  • Garden Reach Sh.
    2,745.00 3,535.00(%)
  • GLEN Industries
    164.85 164.85(%)
  • Mishra Dhatu Nig
    457.65 527.00(%)
  • SpiceJet
    40.85 79.90(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Lincoln Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 12683.0
  • ISIN : INE405C01035
556.25 8 (1.52%)
  • As on 16 Jul 2025 (EOD)

  • Today’s Low

    548.95

  • Today’s High

    561.35

  • Open

    548.95

  • Perv Close

    547.90

  • 52W Low

    499.00

  • 52W High

    979.50

Key Indicators

  • P/E(TTM)

    13.51

  • Mar.Cap (₹Cr.)

    1,114.15

  • Div & Yield %

    0.32

  • Book Value(₹)

    335.34

  • Debt-Equity Ratio

    1.52

  • AGM Date

    15-Jul-2025

  • EPS

    41.11

  • P/E Ratio

    13.51

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    1,114.15

  • RONW (%)

    17.04

  • ROCE (%)

    22.35

Score Board

  • Equity (₹ in Cr.)

    20.03

  • BV (₹)

    335.30

  • Sales( ₹ in Cr.)

    623.23

  • NP (in Cr.)

    82.35

  • NP Var(%)

    -11.0

  • Div%

    18.0

  • CPS (₹)

    47.60

  • EPS (₹)

    41.10

  • Traded Value (₹ in Lakhs)

    1,112.45

  • 52 Week High

    979.50

  • 52 Week Low

    499.00

  • Price BSE

    555.0

  • Price NSE

    556.00

  • Market Capital( in Cr.)

    1,112.45

  • P/C Ratio

    11.70

  • P/E Ratio

    13.50

  • Price Vs.BV

    41.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 580.55 510.31 472.08 422.91 376.09 353.04
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 580.55 510.31 472.08 422.91 376.09 353.04
Other Income 34.42 22.48 10.00 5.74 12.13 6.58
Stock Adjustments 5.70 4.24 13.57 -3.67 5.86 -7.33
Total Income 620.67 537.03 495.65 424.98 394.08 352.29
EXPENDITURE :            
Raw Materials 284.04 245.64 232.15 193.26 192.63 169.75
Power and Fuel Cost 11.47 10.25 8.33 7.10 7.57 7.08
Employee Cost 102.90 93.16 79.72 63.20 54.90 48.40
Other Manufacturing Expenses 23.70 19.55 16.61 16.27 14.35 14.58
Selling and Administration Expenses 60.99 54.50 50.88 50.80 49.58 43.25
Miscellaneous Expenses 3.24 2.28 2.50 1.58 3.54 2.34
Employee Benefit Expenses 102.90 93.16 79.72 63.20 54.90 48.40
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 486.34 425.39 390.18 332.20 322.57 285.38
Operating Profit 134.33 111.65 105.47 92.78 71.50 66.90
Interest 1.46 2.03 1.45 1.55 1.98 3.84
Gross Profit 132.87 109.62 104.02 91.23 69.52 63.06
Depreciation 10.62 9.17 8.09 7.56 5.47 4.92
Profit Before Tax 122.25 100.45 95.93 83.67 64.05 58.14
Current Tax 25.44 25.97 25.85 21.17 14.72 14.29
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.49 1.59 0.72 0.25 -0.24 -2.78
Reported Net Profit 93.30 72.90 69.35 62.25 49.56 46.64
Extraordinary Items 1.07 0.37 0.61 -0.09 -0.03 -0.17
Adjusted Net Profit 92.23 72.53 68.74 62.34 49.59 46.81
Adjustment below Net Profit 0.00 0.00 0.00 0.00 -0.62 -0.62
P & L Balance brought forward 417.66 348.26 282.41 220.66 170.09 127.57
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 3.50 3.50 3.50 0.50 7.12 3.50
P & L Balance carried down 507.46 417.66 348.26 282.41 211.92 170.09
Dividend 0.00 0.00 0.00 0.00 3.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 18.00 15.00 15.00 15.00 15.00 15.00
Dividend Per Share(Rs) 1.80 1.50 1.50 1.50 1.50 1.50
Earnings Per Share-Unit Curr 46.58 36.40 34.63 31.08 24.78 23.32
Earnings Per Share(Adj)-Unit Curr 46.58 36.40 34.63 31.08 24.78 23.32
Book Value 295.98 250.86 216.12 182.92 152.25 131.30
Book Value(Adj)-Unit Curr 295.98 250.86 216.12 182.92 152.25 131.30

Shareholding Pattern

  • Promoter Group

    49.78%

  • Public Share Holding

    50.22%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 8,888,930 44.38 8,888,930 22
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 9,969,930 49.78 9,969,930 25
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,029,255 5.14 1,029,255 53
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 359 0.00 359 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,819 0.01 1,819 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,031,433 5.15 1,031,433 56
2] Non Institution
Bodies Corporate 275,770 1.38 275,770 142
Clearing Members 146 0.00 146 2
Directors of their Relatives 478,400 2.39 478,400 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 441,104 2.20 441,104 628
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 487,565 2.43 487,565 669
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,081,608 10.39 2,081,608 42
Individuals holding nominal share capital up to Rs. 1 lakh 5,182,791 25.88 5,084,667 30,198
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 55,926 0.28 55,926 3
Sub Total 9,028,365 45.07 8,930,241 31,703
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 20,029,728 100.00 19,931,604 31,784

Company Background

Lincoln Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Lincoln Pharmaceuticals Ltd
  • BSE Code : 12683.0
  • ISIN : INE405C01035

  • Incorporation Year

    1995

  • Registered Office

    Lincoln House B/H Satyam Compe
    Science City Road Sola, Ahmedabad,
    Gujarat-380060

  • Telephone

    91-079-67778000

  • FAX

    91-079-67778062

  • Chairman

    Kishorbhai M Shah

  • Managing Director

    Mahendra G Patel

  • Company Secretary

    Trusha Shah

  • Auditor

    Samir M Shah & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road,Navrangpura
    Mumbai - Ahmedabad-380009

Lincoln Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Lincoln Pharma. 555.40 614.97 580.55 13.51 22.35
Abbott India 34,324.90 6,097.18 5,848.91 51.57 44.71
Astrazeneca Phar 9,164.10 1,330.33 1,295.53 197.93 33.26
P & G Health Ltd 5,864.40 1,166.89 1,151.26 38.75 39.76
Glaxosmi. Pharma 3,199.90 3,866.05 3,723.49 58.98 58.72
Cipla 1,490.90 20,029.57 19,044.85 23.35 21.40
Amrutanjan Healt 721.10 437.58 421.23 41.02 20.84
Fermenta Biotec. 386.05 315.24 307.09 16.81 4.10
Guj. Themis Bio. 359.90 174.19 169.82 80.33 44.82
Bliss GVS Pharma 154.40 703.42 667.20 23.61 9.16
Ambalal Sarabhai 35.82 19.33 4.04 33.17 2.10